In recent years, bats have been identified as a natural reservoir for a diverse range of viruses. Nelson Bay orthoreovirus (NBV) was first isolated from the heart blood of a fruit bat (Pteropus poliocephalus) in 1968. While the pathogenesis of NBV remains unknown, other related members of this group have caused acute respiratory disease in humans. Thus the potential for NBV to impact human health appears plausible. Here, to increase our knowledge of NBV, we examined the replication and infectivity of NBV using different mammalian cell lines derived from bat, human, mouse and monkey. All cell lines supported the replication of NBV; however, L929 cells showed a greater than 2 log reduction in virus titre compared with the other cell lines. Furthermore, NBV did not induce major cytopathic effects in the L929 cells, as was observed in other cell lines. Interestingly, the related Pteropine orthoreoviruses, Pulau virus (PulV) and Melaka virus (MelV) were able to replicate to high titres in L929 cells but infection resulted in reduced cytopathic effect. Our study demonstrates a unique virus-host interaction between NBV and L929 cells, where cells effectively control viral infection/replication and limit the formation of syncytia. By elucidating the molecular mechanisms that control this unique relationship, important insights will be made into the biology of this fusogenic virus.
INTRODUCTION
Bats are now recognized as a natural reservoir for a number of highly pathogenic zoonotic viruses including SARS-like coronavirus (Li et al., 2005) , Hendra virus (Murray et al., 1995) , Nipah virus (Chua et al., 2000) and Ebola virus (Leroy et al., 2005) . Indeed, a recent systematic review showed bats harbour more zoonotic viruses than rodents (Luis et al., 2013) . Spill-over events from bats into humans -often either through an intermediate or amplifying hostare often fatal (Chua et al., 2000; Jahrling et al., 2007; Westbury, 2000) . Nelson Bay orthoreovirus (NBV) is a member of the Orthoreovirus genus of the Reoviridae family. The virus was first isolated from the heart blood of a wild Grey-headed flying fox (Pteropus poliocephalus) (Gard & Compans, 1970) . NBV is a member of the proposed group, Pteropine orthoreovirus, formerly known as Nelson Bay orthoreovirus (Voon et al., 2011) . Like other members of the Pteropine orthoreovirus species, NBV is non-enveloped and contains a segmented genome composed of dsRNA. The genome comprises ten segments being divided into three classes based on size, including four small (s), three medium (m) and three large (l) segments. The majority of these segments encode one protein; however, the s1 segment across various species can encode up to three proteins (Duncan et al., 2004; Knipe & Howley, 2007) .
To date, there have been no reports of human infections by NBV. Other viruses within the Pteropine orthoreovirus species have also been isolated from bats, including Pulau virus (PulV) (Pritchard et al., 2006) and Xi River virus (Du et al., 2010) . However, like NBV, there have been no reports of disease in humans from these viruses. In contrast, other Pteropine orthoreovirus species such as Kampar virus (Chua et al., 2008) , Melaka virus (MelV) (Chua et al., 2007) , Sikamat virus (Chua et al., 2011) , HK46886/09, HK50842/10 and HK23629/07 (Cheng et al., 2009; Wong et al., 2012) have been isolated from patients exhibiting clinical disease. These patients were reported to have a close association with bats. The symptoms caused by these viruses were similar to those caused by mammalian orthoreoviruses (MRV) and involved the enteric, respiratory and central nervous systems. There has been limited study on NBV since it was first described in 1970 (Gard & Compans, 1970) . Previous studies have included infections of mice and have shown that intracerebral inoculation of suckling mice causes encephalitis, lethargy, paralysis and eventual death (Gard & Marshall, 1973) . However, the intranasal and subcutaneous inoculation of adult mice (BALB/c) resulted in no observable disease symptoms (Grimley, 2014) . Infection studies of a number of cell lines have also been conducted and large syncytia formation was observed in NBV infected primary cynomolgus monkey kidney cells, pig kidney cells, chicken embryo fibroblast cells and Syrian hamster kidney cells (Gard & Compans, 1970; Gard & Marshall, 1973; Wilcox & Compans, 1982) .
Considering that other Pteropine orthoreovirus species have been transmitted to humans, the potential transmission of NBV from bats to animals and humans appears plausible. The study presented here is the first step in increasing our understanding of the infectivity of this bat borne virus. We have conducted infectivity trails of six mammalian cell lines: Pteropus alecto kidney cells (PaKiT03) (Crameri et al., 2009) , human embryonic kidney cells (HEK293), African green monkey kidney cells (Vero), murine fibroblast cells (L929), murine renal proximal tubular epithelial cells (MCT) and human embryonic fibroblast cells (HEF) and examined the replication kinetics of NBV over a 72 h timecourse. In addition, we examined the impact of NBV on host cell viability and the morphological changes associated with infection. Interestingly, we showed that while all cells are capable of supporting NBV replication, the mouse L929 fibroblasts were significantly less permissive to infection compared to the other cell lines. Furthermore, we show that NBV infected L929 cells do show the cytopathic effects which are characteristic of fusogenic orthoreoviruses.
RESULTS

Cytopathic effect of NBV in mammalian cell lines
NBV successfully infected all cell lines tested and the cytopathic effect (CPE) was characterized by the formation of syncytia. This was first observed at 24 h post-infection (p.i.) in all cell lines with the L929 cells showing only a small dense region of cells at this time point (Fig. 1a) . Overall, there was considerable variation in the magnitude and nature of CPE observed between the cell lines at the different time points. In the HEK293 and MCT infected cells, large dense multinucleated cells were observed at all time points. In contrast, syncytia events were less pronounced in the HEF, PaKiT03 and Vero cells at 24 h p.i., with no large round bodies of cells seen (Fig. 1a) . By 72 h p.i., these cell lines also displayed cell rounding and accumulation of cell bodies forming dark masses. At this time point, the L929 cells continued to display only a single small localized region of syncytia as observed at 24 h p.i. (result not shown).
The viability of cells decreased at 24, 48 and 72 h p.i. in all cell lines except in L929 culture, and the luminescent signal in L929 cells remained constant up to 72 h p.i. The cell viability of MCT cells also remained relatively less affected compared to the other cell lines (Fig. 1b) .
Virus replication and detection of NBV s proteins Viral replication was observed in all cell lines (Fig. 2a) . In agreement with the cytopathic observations, no viral replication as measured by TCID 50 ml 21 could be detected before 24 h p.i. Replication of NBV appeared greatest in the MCT cells with a viral titre of 10 4.8 TCID 50 ml
21
. At 48 h p.i., replication of virus in PaKiT03 cells increased to a similar titre in MCT cells. By 72 h p.i., the PaKiT03 cell line produced the highest level of infectious virus particles with a titre of 10 5.5 TCID 50 ml
. In contrast, virus replication was lowest in the L929 cells compared to all other cell lines at every time point with approximately a 2-3 log difference at 72 h p.i. in the PaKiT03 cells.
Specific antisera were raised against NBV s, m and l proteins. The antiserum for NBV s proteins: s2, a major outer capsid protein and sNS, a non-structural protein with a predicted poly(C)-dependent poly(G) polymerase activity (Gomatos et al., 1981) had the best sensitivity and was used in this study. The relative abundance of these s proteins was compared using immunodetection on cell homogenates of infected cells at 0, 8, 24, 48 and 72 h p.i. NBV s proteins were detected in all cell lines by 24 h p.i. (Fig. 2b ).
Detectable viral s protein levels continued to increase at each time point in PaKiT03 and Vero cells, but in HEK293, HEF and MCT cells, the level of viral s proteins decreased between 24 and 72 h p.i. Overall, the detectable amount of NBV s proteins was lowest in the L929 cells at all time points; it increased between 24 and 48 h p.i. with no further increase at 72 h p.i. (Fig. 2b ).
Morphology of NBV infected PaKiT03 and L929 cells
Considering the difference in NBV infectivity and replication in L929 cells in comparison with other cells, we next set out to examine morphological changes associated with NBV infection using confocal fluorescence microscopy. L929 and PaKiT03 cells were infected with NBV and analysed at denser time points at 8, 16, 18, 20, 23, 39 and 72 h p.i. Fixed cells were probed with specific antibodies for the presence of s proteins, and CPE was analysed by confocal fluorescence microscopy ( Fig. 3a) . The progression of NBV infected PaKiT03 cells produced larger syncytia, consisting of approximately 20-30 nuclei at 16 h p.i. and of multiple regions where syncytia included .200 nuclei at 39 h p.i. (Fig. 3b ). At this time point, there were also large patches observed in the PaKiT03 cell monolayer caused by the detachment and fusion of cells. At 72 h p.i., the majority of cells had detached from the surface (result not shown). In contrast, in L929 cells the infection was manifested by only small regions of syncytia consisting of only 2-6 nuclei from 16-23 h p.i. (Fig. 3a ). There were smaller syncytia with a low number of nuclei contributing observed at 39 and 72 h p.i. (result not shown) (Fig. 3b ).
Low density infection of L929 and PaKiT03 cells
To investigate the influence of cell fusion on viral replication, we examined virus infection at low cell densities. We found that virus was still able to replicate during the infection of L929 and PaKiT03 cells at a low cell density. The virus titre from the infection of PaKiT03 cells was still higher than that in L929 cells at all time points. However, the virus replication up to 24 h p.i. was somewhat similar in the two cell lines, with a titre of 10 2.9 TCID 50 ml 21 for L929 cells and 10 3.5 TCID 50 ml 21 for PaKiT03 cells (Fig. 4a) . At this stage, the morphological changes were not pronounced and similar in both cell types (Fig. 4b) . At 48 and 72 h p.i., the difference in replication of virus between the two cell types was increasingly visible, with the replication in L929 markedly lagging (Fig. 4a) . Syncytia, fewer and smaller in comparison with high cell density cultures, still occurred in both cell lines at this stage, albeit at a lower intensity in L929 cells (Fig. 4b) . At 39 h p.i., the difference in cell morphology was the most pronounced ( Fig. 4b) .
Infection of L929 and PaKiT03 cells with PulV and MelV
To examine infection of two related Pteropine orthoreoviruses, both L929 and PaKiT03 cells were also infected with MelV and PulV, and the resultant virus titres were found to be similar in both cell lines. ). However, at 72 h p.i., replication increased and produced the highest amount of infectious virus particles of 10 6.33 TCID 50 ml 21 (Fig. 5a ).
CPE was observable in both cell lines at 72 h p.i. However, the intensity of CPE was markedly different. Clustering of cells was observed in L929 cells infected with both PulV and MelV, and it was visible that cells had continued to grow around these clumps. On the other hand, in PaKiT03 cells, there was accumulation of cell bodies forming dark masses with no cells (Fig. 5b) . 
DISCUSSION
While all cell types examined in this study were susceptible to NBV infection, there was a marked difference in the permissiveness between the cell lines. Interestingly, the interferon deficient Vero cells (Desmyter et al., 1968) did not produce the highest titre of virus over the time-course, showing a comparable ability and even being outperformed by some of the tested cell lines in replicating NBV. On the other hand, the L929 mouse fibroblast cells were much less susceptible to infection -observed through immunofluorescence microscopy -and were less efficient in supporting the replication of NBV once infected. The other murine cell line, MCT, was highly permissive to NBV and produced high titres of virus, thus suggesting that the phenotype observed in L929 cells is not representative of all murine cells. This is not the first report of L929 cells failing to replicate an orthoreovirus. It has been shown previously that the ARV strain S113 replicated poorly in L929 cells (Spandidos & Graham, 1976) . This restricted replication was overcome with a modification to an acidic pH. It was suggested that the pH of the medium played a role in the attachment of virus to the cell (Mallo et al., 1991) . However, the exact mechanism is yet to be fully elucidated. Given the close phylogenetic relationship between ARV and NBV (Chua et al., 2011; Voon et al., 2011) , this mechanism may also be in place during NBV infection of L929 cells. Interestingly, previous studies have shown that L929 cells are quite susceptible to MRV infection and are the cell line of choice for propagation of MRV (Knipe & Howley, 2007; Nibert & Duncan, 2011; Thompson & Coffey, 2004) .
The infection of cells by MelV and PulV, two Pteropine orthoreoviruses closely related to NBV (Chua et al., 2007; Pritchard et al., 2006) , revealed that both cell lines were able to support virus replication but with CPE occurring at a reduced intensity in the L929 cells. A distinct difference observed in the L929 cells was that other cells had continued to grow around the clumps of cells (Fig. 4b) . Potentially, the mechanism that is occurring between NBV and L929 cells may also be in place between MelV and PulV infection, though at a reduced level.
One of the hallmarks of fusogenic orthoreoviruses, such as NBV, is their ability to induce the formation of syncytia after infecting cells. The NBV fusion associated small transmembrane protein, p10, which is encoded by the s1 genome segment, is responsible for cell fusion and thus confers the ability to induce syncytia during infection (Shmulevitz & Duncan, 2000) . Interestingly, while extensive syncytia were observed in PaKiT03 cells infected with We next examined the progression of syncytia formation during viral replication in PaKiT03 and L929 cells. When both cell types were infected with NBV at a low cell density, the virus appeared to replicate at a very similar rate at 24 h p.i., with minimal syncytia formation most likely caused by the dispersion of cells (Fig. 4a) . As replication of the virus increased in PaKiT03 cells, this was accompanied by an increase in the formation of larger and denser syncytia and cell death. However, in L929 cells syncytia formation appeared to be hindered, resulting in lower virus titres (Fig.  4a ) and the stable cell viability (Fig. 1b) . The decreased ability to induce syncytia resulted in reduced replication of virus and in turn, a lower amount of viral protein produced. On the other hand, an increase in virus replication in PaKiT03 cells progressed with the increased CPE intensity (through syncytia formation) and a decline in cell viability.
Other studies have linked syncytia formation to an increase in progeny virus release, as well as possibly acting as a virulence factor aiding in the evasion of the immune system (Bodeló n et al., 2002; Duncan & Sullivan, 1998; Duncan et al., 1996; Salsman et al., 2005) .
The mechanism by which syncytia formation is controlled by NBV or L929 cells still needs to be elucidated. To address these questions, it will be important to characterize the hostpathogen interaction between NBV and L929 cells, and compare these with processes occurring during infection of PaKiT03 cells at the molecular level. We plan to utilize an integrated approach, known as proteomics informed by transcriptomics (Evans et al., 2012) , to examine changes in gene and protein expression in L929 infected cell lines. In this study, we have demonstrated that NBV is capable of infecting and replicating in mammalian cells derived from human, mouse, monkey and bat, and that L929 murine cells are less susceptible to NBV infection/replication compared to other cell lines. This is manifested through a low virus titre, low levels of viral protein production and reduction in CPE. In addition, the infection of L929 cells with MelV and PulV found that both viruses were able to replicate to titres similar to those obtained in PaKiT03 cells, though the extensiveness of syncytia formation was reduced in L929 cells.
To our knowledge, this is the first identification of a mammalian cell line which demonstrates a reduced permissiveness to the fusogenic virus, NBV. Elucidating the mechanism(s) that confers this phenotype would have broad implications for understanding the influence of host factors in the pathogenesis and replication of other fusogenic viruses. (1988) were obtained from Professor Sharon Ricardo (Monash University). HEF were obtained from Professor Martin Pera (University of Melbourne) and Dr Anna Michalska (University of Melbourne) and were maintained in DMEM with high glucose, GlutaMAX, 25 mM HEPES (Life Technologies) and supplemented with 10 % FCS. All cells were maintained at 37 uC. All cell lines were also tested for the presence of Mycoplasma, returning a negative result.
METHODS
Propagation of NBV stocks. Plaque purified fifth passage NBV was grown in 36 T150 cm 2 flasks (Corning) containing 80-90 % confluency Vero cells in MEM with 2 % FCS (30 ml) and incubated at 37 uC for 72 h. After incubation, the cultures were frozen in the flasks at 280 uC and freeze-thawed once. The contents of each flask were poured into a 50 ml tube and centrifuged at 3000 g for 10 min to remove cellular debris. The supernatant containing virus was then aliquoted into 2 ml cryotubes and stored at 280 uC. The viral titre was determined by titration in Vero cells using the Reed and Muench formula (Reed & Muench, 1938) .
Virus infection of cell lines with NBV, PulV and MelV. Cell lines PaKiT03, HEK293, L929, Vero, MCT and HEF were seeded into 96-well (virus titration and cell viability) and 24-well (virus protein detection) microplates in triplicate and left overnight to incubate at 37 uC, so as to reach approximately 80-90 % confluency the next day. Cell lines in each well were infected with virus inoculum at an m.o.i. of 10. The virus inoculum was left on the cell monolayer for 1 h at 37 uC. Following 1 h incubation, the virus inoculum was removed and wells were washed once with sterile PBS and replaced with 100 ml (virus titration), 1 ml (virus protein detection) or 50 ml (cell viability) of fresh growth media with 10 % FCS.
Titration of virus in Vero cells. Virus titration was performed in Vero cells in 96-well microplates. Following incubation plates were frozen at 280 uC at 0, 8, 24, 48 and 72 h p.i. and freeze-thawed once to lyse cells. The entire contents of the well were moved to a microfuge tube. To measure the TCID 50 , 300 ml of EMEM growth medium was added to the first column of a 96-well microplate. An aliquot of freeze-thawed cell lysate (33 ml) was added to the first well and serially diluted down the plate, and 25 ml was then transferred across the plate. Vero cells were prepared at a concentration of 2610 5 cells ml 21 , and 100 ml of this cell preparation was then added to each well. CPEs were observed after 4 days under light microscopy and the TCID 50 ml 21 was calculated according to the Reed and Muench formula (Reed & Muench, 1938) .
Cell viability. The viability of cells was determined using a CellTiterGlo luminescent assay kit (Promega). This assay is based on a luciferase reaction generating a luminescent signal that is proportional to the amount of ATP present. Following the infection of cells in 96-well microplates, 50 ml of equilibrated room temperature CellTiter-Glo assay reagent was added to each well. The microplates were shaken to mix contents at 500 r.p.m. on a microplate shaker (Eppendorf MixMate) for 2 min. Microplates were then left to incubate for 10 min at room temperature and the luminescence was read using a microplate reader at ambient temperature (BioTek Synergy HT Luminometer).
Sampling of NBV infected cell lines for protein extraction for immunodetection. At the sampling time points, the medium was removed from each well and transferred to a separate microfuge tube. The remaining cells in each well were solubilized with 600 ml of lysis buffer (Qiagen) by gently pipetting up and down, and the cell lysate was transferred to a separate tube.
Cell lysates in lysis buffer were homogenized by spinning through a QIAshredder (Qiagen) at 17 000 g for 2 min. Proteins in the flowthrough were precipitated with 220 uC cold acetone (4 volumes) and kept for 30 min at 220 uC. Precipitated proteins were pelleted by centrifugation at 4700 g for 10 min. The supernatant was discarded and the pellet was left to air dry for 10 min. Precipitated proteins were resuspended in lysis buffer (7 M urea, 2 M thiourea, 4 % CHAPS, 30 mM Tris/HCl, pH 8.8) and quantified using a EZQ Protein Quantification kit (Life Technologies).
Generation of NBV proteins specific polyclonal antibodies. Antisera (polyclonal antibodies) against purified NBV proteins were generated as described by Grimley (2014) . Briefly, NBV was purified by a CsCl gradient and the viral proteins were separated by SDS-PAGE on 4-12 % Bistris gels (Invitrogen). Following electrophoresis, individual protein bands were visualized with ice-cold 0.3 M KCl and the bands corresponding to NBV s, m and l proteins were excised from the gels for protein elution. Proteins were passively eluted twice with 0.1 % SDS in PBS at room temperature overnight and concentrated in an Amicon Ultra-0.5 ml centrifugal filter with a 3 kDa molecular mass cut-off (Merck Millipore). Protein quantification was then performed using a NanoDrop spectrophotometer (Thermo Fisher Scientific) and the identity of extracted proteins was confirmed by mass spectrometric analysis using the method described previously (Petraityte et al., 2009) . The mass spectra were matched against a custom database of NBV protein sequences. The antibodies against s, m and l NBV proteins were raised in rabbits using CSIRO Triple Adjuvant (Prowse, 2008) with two injections of approximately 30 mg protein 3 weeks apart. Collected antisera were tested against respective antigens and were found to be specific. The antisera against NBV s proteins had the best sensitivity were used in immunodetection in Western blotting and in confocal fluorescence microscopy.
SDS-PAGE and immunodetection. Samples were taken for the immunodetection of viral proteins at each of the time points. Proteins were extracted from the entire contents of a 24-well well microplate and each of the samples was quantified prior to analysis. A total of 20 mg of total protein from samples was separated by electrophoresis, electrotransferred and probed with a primary antibody specific to detect the s proteins of NBV.
Protein samples were separated under reducing conditions on precast 4-12 % Bistris gels in MOPS buffer (Life Technologies). Samples were transferred onto a PVDF membrane in CAPS buffer. The membrane was blocked overnight at 4 uC with 5 % skim milk in Tris buffered saline with 5 % Tween-20 (TBST). The membrane was probed with rabbit sera raised against NBV s protein (1/1000) and followed with goat anti-rabbit IgG conjugated with HRP (1/2000). Bands were visualized with Pierce enhanced chemiluminescence plus reagents (Thermo Fisher Scientific) and exposure to X-ray film (Fuji film).
Preparation of cells for confocal fluorescence microscopy.
PaKiT03 and L929 cells were seeded at 1.2610 5 cells per glass coverslip in a 24-well microplate. For low cell density studies, PaKiT03 and L929 cells were seeded at 3.2610 4 cells per glass coverslip and left to adhere overnight. Cells were infected with virus inoculum at an m.o.i. of 10 and were incubated for 1 h at 37 uC. After incubation, the virus inoculum was removed and replaced with fresh media containing 10 % FCS. After 8, 16, 18, 20, 23, 39 and 72 h p.i., the media was removed and the wells were flooded with fixative (4 % paraformaldehyde in PBS) for 40 min at room temperature. The fixative was removed after this incubation and coverslips were washed three times with PBS. Coverslips were then treated with 0.1 % Triton X-100 for 10 min and blocked with 0.5 % BSA in PBS for 30 min. Coverslips were incubated with NBV s protein specific antibody (1/ 500 diluted in 0.5 % BSA in PBS) for 1 h and then washed three times with PBS for 5 min. A secondary antibody (Alexa Fluor 488, Life Technologies) was then added to the coverslips for 1 h and then washed twice with PBS for 5 min. The nuclei of the cells were labelled with DAPI for 10 min and the coverslips were mounted on to glass slides with Vectashield.
